Genetic Signatures Ltd has released a press release.
Investor Presentation
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
In the deck
Story so far
Earlier from Genetic Signatures
- Update to major customer contract announcement
- Major Customer Contract Signed, New Kit and Instrument
- TGA registration for superbug detection kits
- Positive Trial Results Presented at ECCMID
- Appendix 4D and Half Year Financial Statements
Later from Genetic Signatures
- Additional Tax Incentive from understatement FY17 R&D Claim
- Appendix 4E and 2018 Financial Report
- Chairmans Address to Shareholders
- $2.6m R&D refund received
- CE-IVD Mark for Respiratory Pathogen Detection Kit
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures